Phase I trial of CC8464 for the treatment of pain
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2017
At a glance
- Drugs CC 8464 (Primary)
- Indications Pain
- Focus Adverse reactions
- 27 Jun 2017 According to a Chromocell Corporation media release, the company received an additional milestone payment from Astellas Pharmaceuticals Inc. for the initiation of the multiple ascending dose portion of this trial.
- 06 Oct 2015 New trial record
- 30 Sep 2015 According to an Astellas Pharma media release, Chromocell anticipates filing an IND for CC8464 in early 2016.